vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $733.7M, roughly 1.3× BRIGHT HORIZONS FAMILY SOLUTIONS INC.). On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 8.8%). BRIGHT HORIZONS FAMILY SOLUTIONS INC. produced more free cash flow last quarter ($258.5M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 8.5%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Bright Horizons Family Solutions Inc. is a United States–based child-care provider and is the largest provider of employer-sponsored child care. It also provides back-up child care and elder care, tuition program management, education advising, and student loan repayment programs. It is headquartered in Newton, Massachusetts.
ASTH vs BFAM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $733.7M |
| Net Profit | $6.6M | — |
| Gross Margin | — | 19.3% |
| Operating Margin | 1.9% | 6.2% |
| Net Margin | 0.7% | — |
| Revenue YoY | 42.9% | 8.8% |
| Net Profit YoY | 184.4% | — |
| EPS (diluted) | $0.12 | $0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $733.7M | ||
| Q3 25 | $956.0M | $802.8M | ||
| Q2 25 | $654.8M | $731.6M | ||
| Q1 25 | $620.4M | $665.5M | ||
| Q4 24 | $665.2M | $674.1M | ||
| Q3 24 | $478.7M | $719.1M | ||
| Q2 24 | $486.3M | $670.1M | ||
| Q1 24 | $404.4M | $622.7M |
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $78.6M | ||
| Q2 25 | $9.4M | $54.8M | ||
| Q1 25 | $6.7M | $38.0M | ||
| Q4 24 | $-7.8M | — | ||
| Q3 24 | $16.1M | $54.9M | ||
| Q2 24 | $19.2M | $39.2M | ||
| Q1 24 | $14.8M | $17.0M |
| Q4 25 | — | 19.3% | ||
| Q3 25 | — | 27.0% | ||
| Q2 25 | — | 25.0% | ||
| Q1 25 | — | 23.4% | ||
| Q4 24 | — | 20.8% | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | — | 24.2% | ||
| Q1 24 | — | 21.7% |
| Q4 25 | 1.9% | 6.2% | ||
| Q3 25 | 2.0% | 15.1% | ||
| Q2 25 | 3.1% | 11.8% | ||
| Q1 25 | 3.3% | 9.4% | ||
| Q4 24 | 0.1% | 7.2% | ||
| Q3 24 | 5.9% | 12.4% | ||
| Q2 24 | 6.2% | 10.3% | ||
| Q1 24 | 7.5% | 6.4% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | 9.8% | ||
| Q2 25 | 1.4% | 7.5% | ||
| Q1 25 | 1.1% | 5.7% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 3.4% | 7.6% | ||
| Q2 24 | 3.9% | 5.8% | ||
| Q1 24 | 3.7% | 2.7% |
| Q4 25 | $0.12 | $0.38 | ||
| Q3 25 | $0.01 | $1.37 | ||
| Q2 25 | $0.19 | $0.95 | ||
| Q1 25 | $0.14 | $0.66 | ||
| Q4 24 | $-0.14 | $0.50 | ||
| Q3 24 | $0.33 | $0.94 | ||
| Q2 24 | $0.40 | $0.67 | ||
| Q1 24 | $0.31 | $0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $140.1M |
| Total DebtLower is stronger | — | $747.6M |
| Stockholders' EquityBook value | $779.3M | $1.3B |
| Total Assets | $2.2B | $3.9B |
| Debt / EquityLower = less leverage | — | 0.56× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $140.1M | ||
| Q3 25 | $463.4M | $116.6M | ||
| Q2 25 | $342.1M | $179.2M | ||
| Q1 25 | $260.9M | $112.0M | ||
| Q4 24 | $290.8M | $110.3M | ||
| Q3 24 | $350.3M | $109.9M | ||
| Q2 24 | $327.7M | $140.2M | ||
| Q1 24 | $337.3M | $63.7M |
| Q4 25 | — | $747.6M | ||
| Q3 25 | — | $747.5M | ||
| Q2 25 | — | $797.0M | ||
| Q1 25 | — | $872.7M | ||
| Q4 24 | — | $918.4M | ||
| Q3 24 | — | $925.7M | ||
| Q2 24 | — | $931.9M | ||
| Q1 24 | — | $938.1M |
| Q4 25 | $779.3M | $1.3B | ||
| Q3 25 | $775.5M | $1.4B | ||
| Q2 25 | $765.5M | $1.4B | ||
| Q1 25 | $745.4M | $1.3B | ||
| Q4 24 | $712.7M | $1.3B | ||
| Q3 24 | $704.6M | $1.4B | ||
| Q2 24 | $678.9M | $1.3B | ||
| Q1 24 | $653.5M | $1.2B |
| Q4 25 | $2.2B | $3.9B | ||
| Q3 25 | $2.2B | $3.9B | ||
| Q2 25 | $1.4B | $3.9B | ||
| Q1 25 | $1.3B | $3.8B | ||
| Q4 24 | $1.4B | $3.9B | ||
| Q3 24 | $1.3B | $3.9B | ||
| Q2 24 | $1.3B | $3.8B | ||
| Q1 24 | $1.2B | $3.8B |
| Q4 25 | — | 0.56× | ||
| Q3 25 | — | 0.52× | ||
| Q2 25 | — | 0.57× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.72× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.73× | ||
| Q1 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $350.7M |
| Free Cash FlowOCF − Capex | $-6.0M | $258.5M |
| FCF MarginFCF / Revenue | -0.6% | 35.2% |
| Capex IntensityCapex / Revenue | 0.3% | 12.6% |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $402.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $350.7M | ||
| Q3 25 | $10.0M | $-17.6M | ||
| Q2 25 | $90.9M | $134.2M | ||
| Q1 25 | $16.6M | $86.2M | ||
| Q4 24 | $-10.9M | $337.5M | ||
| Q3 24 | $34.0M | $-8.9M | ||
| Q2 24 | $23.2M | $109.4M | ||
| Q1 24 | $6.0M | $116.3M |
| Q4 25 | $-6.0M | $258.5M | ||
| Q3 25 | $7.4M | $-42.4M | ||
| Q2 25 | $89.5M | $115.4M | ||
| Q1 25 | $13.6M | $70.9M | ||
| Q4 24 | $-13.5M | $240.2M | ||
| Q3 24 | $31.7M | $-32.2M | ||
| Q2 24 | $20.4M | $86.8M | ||
| Q1 24 | $5.6M | $96.9M |
| Q4 25 | -0.6% | 35.2% | ||
| Q3 25 | 0.8% | -5.3% | ||
| Q2 25 | 13.7% | 15.8% | ||
| Q1 25 | 2.2% | 10.7% | ||
| Q4 24 | -2.0% | 35.6% | ||
| Q3 24 | 6.6% | -4.5% | ||
| Q2 24 | 4.2% | 13.0% | ||
| Q1 24 | 1.4% | 15.6% |
| Q4 25 | 0.3% | 12.6% | ||
| Q3 25 | 0.3% | 3.1% | ||
| Q2 25 | 0.2% | 2.6% | ||
| Q1 25 | 0.5% | 2.3% | ||
| Q4 24 | 0.4% | 14.4% | ||
| Q3 24 | 0.5% | 3.2% | ||
| Q2 24 | 0.6% | 3.4% | ||
| Q1 24 | 0.1% | 3.1% |
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | -0.22× | ||
| Q2 25 | 9.65× | 2.45× | ||
| Q1 25 | 2.48× | 2.26× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | -0.16× | ||
| Q2 24 | 1.21× | 2.79× | ||
| Q1 24 | 0.40× | 6.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
BFAM
Segment breakdown not available.
